EMCrit 279 – The Decision to use Ketamine – Disruptive and Dangerous with Reub Strayer - a podcast by Scott D. Weingart, MD FCCM

from 2020-08-09T19:32:42

:: ::





I frequently see both residents and attendings inappropriately using ketamine for agitated patients. Inappropriately both by giving it when it is unecessary and giving it in poor fashion when it is indicated.

Our guest today is Reub Strayer

(@emupdates). He is the author of EMUpdates.com. His research and clinical interests include checklists and standardization, airway, legislative work on the treatment of opioid dependence, and an approach to opioid misuse in the ED.



 



Reub breaks agitated patients down in to 3 groups:





1. Agitated, but Cooperative

Not a problem in the ED. Oral medications or non-pharm techniques.

2. Disruptive without Danger

Use standard anti-psychotics and sedatives, with the understanding that Haldol 5mg and Lorazepam 2 mg given IM will take a long time for full effect and even then, may not provide adequate sedation. There are better choices for this group:



* Droperidol monotherapy 5-10 mg IM or 5 mg IV

* Droperidol 5 mg + Midazolam 2mg IM or IV in the same syringe

* Olanzapine 10 mg IM (Needs Resp Monitoring)

* Olanzapine 5 mg + Midazolam 2 mg IM or IV  (Needs Resp Monitoring)

* Haldol 5 mg + Midazolam 2 mg IM or IV (will be slower than the other choices)



If using standard 5/2 (haldol and lorazepam IM), too much time for effect and impatience leads to the wrong subsequent choice, i.e. giving ketamine to this group.

3. Disruptive and Dangerous



* dangerous to staff, dangerous to self

* danger is relative to the resources of the location



Danger could be due to



* The agitation itself or

* An underlying condition that the agitation is preventing from being treated (and may be the cause of the agitation, e.g. tension pneumothorax)



Dividing Line Question: Would you consider intubation to control the situation if ketamine was not available? Reub calls this the Ketamine Litmus Test.



Ketamine takedown must be treated as Procedural Sedation (1:1 nursing observation)

Intramuscular Medication Administration



* Can go through clothes if you need to [Fleming et al.]

* Reub states maximum volume of up to 20 mls per injection



* Harrington 2005 Administer Single Site 30mL Injection Fosphenytoin - Medsurg Nursing

* Hopkins 2013 Large Volume IM Injections Review of Best Practices (Oncology) - Onc Nurse Advisor

* Ramsay 1997 IM Fosphenytoin Loading High Volumes - Epilepsy Research







Ketamine Brain Continuum

EMCrit Podcast

Further podcasts by Scott D. Weingart, MD FCCM

Website of Scott D. Weingart, MD FCCM